Edge Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Edge Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$11,000
-42.1%
128
-51.9%
0.00%
-50.0%
Q1 2018$19,000
+26.7%
2660.0%0.00%
+100.0%
Q4 2017$15,000
+36.4%
2660.0%0.00%0.0%
Q3 2017$11,000
-35.3%
266
-40.5%
0.00%
-50.0%
Q2 2017$17,0000.0%4470.0%0.00%0.0%
Q1 2017$17,0000.0%447
+1.6%
0.00%0.0%
Q4 2016$17,0004400.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders